DV
Dividend Vision

EVAX — Evaxion Biotech AS

Evaxion Biotech AS (EVAX)

Total return is -99.3% over the past 5.5 years, 215.0 points behind SPY at 115.7%. Its deepest 1-year drawdown was 74.7%.

EVAX is an equity fund that tracks the stock of Evaxion Biotech AS, a biotech company. The fund does not currently have a meaningful distribution rate or yield profile, making it a non-income-generating holding. This structure appeals primarily to growth-oriented investors seeking exposure to biotechnology rather than those focused on dividend income.

EVAX key facts

Asset type
Stock
Asset class
Equity
Inception date
02/05/2021
Last close
$3.34
Market cap
$25,646,162
Average volume
19800.0
Beta
0.263
Payout ratio
0.0
Forward P/E
3.5714
EPS
$-1.00